Wells Fargo & Company Dexcom Inc Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
1 transactions
Others Institutions Holding DXCM
# of Institutions
1,048Shares Held
364MCall Options Held
4.11MPut Options Held
3.63M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.25 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.41 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.14 Billion0.08% of portfolio
-
Baillie Gifford & CO15MShares$1.05 Billion0.77% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$836 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $27B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...